BRIEF published on 11/11/2024 at 07:05, 10 days 7 hours ago LEM Reports Weak First Half for 2024/25 Sales Decline Half Year Results Performance Program Future Outlook LEM Holding
PRESS RELEASE published on 11/11/2024 at 07:00, 10 days 7 hours ago LEM with weak first half in 2024/25 LEM Holding SA reports a weak first half in 2024/25 with sales declining 29.9% to CHF 156.5 million and EBIT down by 72.6%. LEM launches 'Fit for Growth' program to enhance performance Financial Results Sales Decline LEM Holding SA 2024/25 Fit For Growth Program
BRIEF published on 10/22/2024 at 09:05, 30 days 5 hours ago LEM Holding SA to Announce Half Year Results 2024/25 on November 11 Conference Call Investor Relations LEM Holding SA Financial Outlook Half Year Results
PRESS RELEASE published on 10/22/2024 at 09:00, 30 days 5 hours ago Invitation to Conference Call and Audio Webcast 11 November 2024, 10.30 am LEM Holding SA (SIX: LEHN) to announce Half Year Results 2024/25 on 11 November 2024. Conference call and webcast with CEO and CFO on 11th Nov at 10:30 am CET Conference Call Investor Relations LEM Holding SA Half Year Results Audio Webcast
BRIEF published on 07/26/2024 at 07:05, 3 months 26 days ago LEM Reports Significant Sales Decline in Q1 2024/25 with Signs of Stabilization in China Financial Results Sales Decline LEM Q1 2024/25 China Stabilization
PRESS RELEASE published on 07/26/2024 at 07:00, 3 months 26 days ago LEM with significant sales decline in Q1 2024/25 – first signs of stabilization in China LEM Holding SA reports a significant 27.9% sales decline in Q1 2024/25, with first signs of stabilization in China. EBIT decreased by 71.4% China Sales Decline LEM Holding SA Q1 2024/25 Stabilization
BRIEF published on 06/28/2024 at 07:05, 4 months 23 days ago Annual General Meeting of LEM Holding Approves All Proposals Board Of Directors Annual General Meeting Dividends LEM Holding
PRESS RELEASE published on 06/28/2024 at 07:00, 4 months 23 days ago Annual General Meeting of LEM Holding approves all proposals LEM Holding SA's Annual General Meeting approves all proposals with a strong majority. Dividend distribution of CHF 50.00 per share agreed. Board members re-elected. Next AGM scheduled for 26 June 2025 Annual General Meeting Board Members Dividend Distribution LEM Holding SA AGM 2025
BRIEF published on 06/13/2024 at 07:05, 5 months 8 days ago LEM CFO Andrea Borla to Leave by End of November 2024 CFO Finance Succession Andrea Borla LEM Holding
PRESS RELEASE published on 06/13/2024 at 07:00, 5 months 8 days ago CFO Andrea Borla to leave LEM by end of November 2024 CFO Andrea Borla to leave LEM by end of November 2024 after 9 years. Board expresses gratitude for his contributions. Thomas Mellano to lead finance on interim basis CFO Finance Andrea Borla LEM Holding Thomas Mellano
Published on 11/21/2024 at 14:15, 16 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 31 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 31 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 31 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 14 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 15 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 55 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 33 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
